Crossmark

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

Crossref DOI link: https://doi.org/10.1038/s41375-019-0444-6

Published Online: 2019-03-14

Published Print: 2019-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vendramini, Elena

Bomben, Riccardo

Pozzo, Federico

Benedetti, Dania

Bittolo, Tamara

Rossi, Francesca Maria

Dal Bo, Michele

Rabe, Kari G.

Pozzato, Gabriele

Zaja, Francesco

Chiarenza, Annalisa

Di Raimondo, Francesco

Braggio, Esteban

Parikh, Sameer A.

Kay, Neil E.

Shanafelt, Tait D.

Del Poeta, Giovanni

Gattei, Valter

Zucchetto, Antonella
License Information

Text and Data Mining valid from 2019-03-14
More Information

Article History

Received: 4 March 2019

Accepted: 6 March 2019

First Online: 14 March 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.